LLS: Clinical Research – Find a Cure for Blood Cancer
The Leukemia & Lymphoma Society (LLS) is a global leader in the fight against blood cancer. LLS is at the forefront of the fight to cure blood cancer. We are the largest nonprofit dedicated to creating a world without blood cancers. Since 1949, we’ve invested more than $1.6 billion in groundbreaking research, pioneering many of today’s most innovative approaches.
Real-World Evidence Initiative Reports Now Available to Improve Lives of Patients
ASH Research’s mission is fostering high-quality, equitable care, transformative research, and innovative education to improve the lives of patients with blood and bone marrow disorders.
National Blood Clot Alliance: Research for Patients
NBCA works on behalf of people who may be susceptible to blood clots, including, but not limited to, people with clotting disorders, atrial fibrillation, cancer, traumatic injury, and risks related to surgery, lengthy immobility, child birth and birth control. NBCA accomplishes its mission through programs that build public awareness, educate patients and healthcare professionals, and promote supportive public and private sector policy.
Stanford Blood Center: Providing Hope For Future Patients
Stanford Blood Center leads the fields of transfusion and transplantation medicine by advancing science and technology. We provide hope for the future by teaching the medical leaders of tomorrow. We enhance lives by connecting donors to patients every day.
St. Jude Blood Disorders Treatment: Patient Stories
St. Jude is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. The mission of St. Jude Children’s Research Hospital is to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment. Consistent with the vision of our founder Danny Thomas, no child is denied treatment based on race, religion or a family’s ability to pay.
ASH Clinical Transformative Research
ASH Research’s mission is fostering high-quality, equitable care, transformative research, and innovative education to improve the lives of patients with blood and bone marrow disorders.
NHF: Advocacy Do’s and Don’ts
The National Hemophilia Foundation (NHF) is dedicated to finding cures for inheritable blood disorders and to addressing and preventing the complications of these disorders through research, education, and advocacy enabling people and families to thrive.
Sickle Cell: Patient-Focused Clinical Research
The Cure Sickle Cell Initiative is a collaborative, patient-focused research effort designed to accelerate promising genetic therapies to cure sickle cell disease. The Initiative considers non-traditional ways to advance research and brings together the sickle cell disease (SCD) community—patients, advocates, caregivers, providers, researchers, industry, and others.
Improving Research to Build a Brighter Future for People with Hematologic Conditions
Find community and information on sickle cell and other hematologic (blood disorders) conditions. The ASH Research Collaborative (ASH RC) is a non-profit organization established by the American Society of Hematology (ASH) in 2018 to improve the lives of people affected by blood diseases by fostering collaborative partnerships to accelerate progress in hematology.